Comprehensive analysis of prognostic alternative splicing signature in cervical cancer

Abstract Background Alternative splicing (AS) is a key factor in protein-coding gene diversity, and is associated with the development and progression of malignant tumours. However, the role of AS in cervical cancer is unclear. Methods The AS data for cervical squamous cell carcinoma and endocervica...

Full description

Bibliographic Details
Main Authors: Dong Ouyang, Ping Yang, Jing Cai, Si Sun, Zehua Wang
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Cancer Cell International
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12935-020-01299-4
_version_ 1811212029015359488
author Dong Ouyang
Ping Yang
Jing Cai
Si Sun
Zehua Wang
author_facet Dong Ouyang
Ping Yang
Jing Cai
Si Sun
Zehua Wang
author_sort Dong Ouyang
collection DOAJ
description Abstract Background Alternative splicing (AS) is a key factor in protein-coding gene diversity, and is associated with the development and progression of malignant tumours. However, the role of AS in cervical cancer is unclear. Methods The AS data for cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) were downloaded from The Cancer Genome Atlas (TCGA) SpliceSeq website. Few prognostic AS events were identified through univariate Cox analysis. We further identified the prognostic prediction models of the seven subtypes of AS events and assessed their predictive power. We constructed a clinical prediction model through global analysis of prognostic AS events and established a nomogram using the risk score calculated from the prognostic model and relevant clinical information. Unsupervised cluster analysis was used to explore the relationship between prognostic AS events in the model and clinical features. Results A total of 2860 prognostic AS events in cervical cancer were identified. The best predictive effect was shown by a single alternate acceptor subtype with an area under the curve of 0.96. Our clinical prognostic model included a nine-AS event signature, and the c-index of the predicted nomogram model was 0.764. SNRPA and CCDC12 were hub genes for prognosis-associated splicing factors. Unsupervised cluster analysis through the nine prognostic AS events revealed three clusters with different survival patterns. Conclusions AS events affect the prognosis and biological progression of cervical cancer. The identified prognostic AS events and splicing regulatory networks can increase our understanding of the underlying mechanisms of cervical cancer, providing new therapeutic strategies.
first_indexed 2024-04-12T05:21:57Z
format Article
id doaj.art-fc9171880fb34dd195b5db144924233f
institution Directory Open Access Journal
issn 1475-2867
language English
last_indexed 2024-04-12T05:21:57Z
publishDate 2020-06-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj.art-fc9171880fb34dd195b5db144924233f2022-12-22T03:46:26ZengBMCCancer Cell International1475-28672020-06-0120111510.1186/s12935-020-01299-4Comprehensive analysis of prognostic alternative splicing signature in cervical cancerDong Ouyang0Ping Yang1Jing Cai2Si Sun3Zehua Wang4Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Obstetrics and Gynecology, First Affiliated Hospital, School of Medicine, Shihezi UniversityDepartment of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyDepartment of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyAbstract Background Alternative splicing (AS) is a key factor in protein-coding gene diversity, and is associated with the development and progression of malignant tumours. However, the role of AS in cervical cancer is unclear. Methods The AS data for cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) were downloaded from The Cancer Genome Atlas (TCGA) SpliceSeq website. Few prognostic AS events were identified through univariate Cox analysis. We further identified the prognostic prediction models of the seven subtypes of AS events and assessed their predictive power. We constructed a clinical prediction model through global analysis of prognostic AS events and established a nomogram using the risk score calculated from the prognostic model and relevant clinical information. Unsupervised cluster analysis was used to explore the relationship between prognostic AS events in the model and clinical features. Results A total of 2860 prognostic AS events in cervical cancer were identified. The best predictive effect was shown by a single alternate acceptor subtype with an area under the curve of 0.96. Our clinical prognostic model included a nine-AS event signature, and the c-index of the predicted nomogram model was 0.764. SNRPA and CCDC12 were hub genes for prognosis-associated splicing factors. Unsupervised cluster analysis through the nine prognostic AS events revealed three clusters with different survival patterns. Conclusions AS events affect the prognosis and biological progression of cervical cancer. The identified prognostic AS events and splicing regulatory networks can increase our understanding of the underlying mechanisms of cervical cancer, providing new therapeutic strategies.http://link.springer.com/article/10.1186/s12935-020-01299-4ASNomogramPrognosisSplicing factorThe Cancer Genome AtlasCervical cancer
spellingShingle Dong Ouyang
Ping Yang
Jing Cai
Si Sun
Zehua Wang
Comprehensive analysis of prognostic alternative splicing signature in cervical cancer
Cancer Cell International
AS
Nomogram
Prognosis
Splicing factor
The Cancer Genome Atlas
Cervical cancer
title Comprehensive analysis of prognostic alternative splicing signature in cervical cancer
title_full Comprehensive analysis of prognostic alternative splicing signature in cervical cancer
title_fullStr Comprehensive analysis of prognostic alternative splicing signature in cervical cancer
title_full_unstemmed Comprehensive analysis of prognostic alternative splicing signature in cervical cancer
title_short Comprehensive analysis of prognostic alternative splicing signature in cervical cancer
title_sort comprehensive analysis of prognostic alternative splicing signature in cervical cancer
topic AS
Nomogram
Prognosis
Splicing factor
The Cancer Genome Atlas
Cervical cancer
url http://link.springer.com/article/10.1186/s12935-020-01299-4
work_keys_str_mv AT dongouyang comprehensiveanalysisofprognosticalternativesplicingsignatureincervicalcancer
AT pingyang comprehensiveanalysisofprognosticalternativesplicingsignatureincervicalcancer
AT jingcai comprehensiveanalysisofprognosticalternativesplicingsignatureincervicalcancer
AT sisun comprehensiveanalysisofprognosticalternativesplicingsignatureincervicalcancer
AT zehuawang comprehensiveanalysisofprognosticalternativesplicingsignatureincervicalcancer